Interventional Neurology Market

Global Interventional Neurology Market Overview

The Interventional neurology Market is projected to reach USD 2.57 Billion by 2032 at 5.1% CAGR during the forecast period 2023-2032.

The interventional neurology machines help diagnose, prevent, and treat various neurological diseases and conditions such as Alzheimer's, Parkinson's disease, major depressive disorder, epilepsy, spinal cord injury, and traumatic brain injury. These devices are less aggressive photographic technology. The procedures involving these devices are used to diagnose and treat head, neck and spinal diseases. With the growth of the world's population and the survival rate, neurological disorders are increasing worldwide. As for intervening, the neurology machines help improve motor functioning in daily life by empowering the patients who control the body's movement.

Royal Philips, a global leader in health technology, today announced the launch of its new Azurion neuro biplane system, which includes significant improvements to its Image Guided Therapy System, Azurion. The new interventional system is engineered to optimize neurovascular procedures, assist care teams in making accurate decisions more quickly, treat a greater number of patients, and achieve superior results. It boasts improved 2D and 3D imaging capabilities and the ability to position the X-ray detector with greater flexibility. Philips is collaborating with its customers to enhance productivity and access to more sustainable healthcare at #ECR2024, as healthcare providers endeavor to provide high-quality care to patients. Interventional systems such as Azurion facilitate minimally invasive procedures, which are a critical component of the stroke diagnosis and treatment pathway. In this context, every minute is crucial in preserving the patient's quality of life. Interventional systems are also employed to precisely plan and execute intricate neurovascular procedures, including the closure of brain aneurysms and birth defects. The new Philips Azurion neuro biplane system improves the staff and patient experience and contributes to a lower cost of care by enabling neuro interventionists to treat a greater number of patients more efficiently and with the potential for improved outcomes. The Azurion neuro biplane image-guided therapy system from Philips is intended to facilitate and enhance procedure workflows in situations where a combination of 2D and 3D imaging is required for precise treatment and confident diagnosis. When integrated with the most recent Neuro Suite software and services from the company, it offers neuro interventionists a fully integrated solution that integrates Philips' world-class ClarityIQ low dose imaging with a variety of neuro-specific tools and value-added services that provide unparalleled levels of efficiency, flexibility, and control.

The neuro thrombectomy device is intended to mechanically retrieve or destroy blood clots in the cerebral neurovascular with laser, ultrasound, or combination. Ischemic acute stroke is associated with side effects and a higher health burden. The use of the Neurothrombectomy equipment is recommended for the patients receiving the treatment that may have limited the functionality. The currently available Neurothrombectomy machines offer interesting treatment options to patients with acute ischemic stroke. The neuro thrombectomy machines provide many potential benefits beyond pharmacologic thrombolysis, including the success of the rapid reconstruction, improved efficiency in the treatment of the large vessel, and a lower risk of bleeding events.

Interventional Neurology Market Segment Insights

The Interventional Neurology Market is segmented based on disease pathology, product, end user and region.

Interventional Neurology Product Insights

The global market for interventional neurology, by disease pathology is segmented into cerebral aneurysms, arteriovenous malformation and fistulas, ischemic strokes, and others.

The market, by product, is segmented into aneurysm coiling & embolization devices, cerebral balloon angioplasty and stenting systems, neurothrombectomy devices, and support devices. The aneurysm coiling & embolization devices segment is further classified as embolic coils, flow diversion devices, and liquid embolic agents. The embolic coils segment includes bare detachable coils, and coated detachable coils. The cerebral balloon angioplasty and stenting systems segment is further classified as carotid artery stents, and embolic protection systems. The embolic protection systems segment includes distal filter devices, and balloon occlusion devices. The neurothrombectomy devices are further classified as clot retrieval devices, suction and aspiration devices, and snares. The support devices are further classified as microcatheters, and microguidewires.

Based on end user, the market is segmented into hospitals & clinics, ambulatory surgical centres, research & academic institutes, and others.

In the current scope of the study, the above-mentioned segments are covered into the four global regions, namely the Americas, Europe, Asia-Pacific and the Middle East & African region.

The interventional neurology market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European interventional neurology market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The interventional neurology market in the Middle East & Africa has been segmented into the Middle East and Africa.

Interventional Neurology Regional Insights

The Americas dominated the global market for interventional neurology owing to presence of major market players and rising geriatric population.

It was estimated that Europe stood second in the Interventional Neurology Market. This can be attributed to the rising research and development investments.

The rising participation of market players is also boosting the interventional neurology market. For instance, in 2018, Rapid Medical announced CE Mark approval in the European Union for its Tigertriever 13 stent retriever for the treatment of ischemic stroke.

Asia Pacific was projected to be the fastest growing region in 2017. Factors such as growing healthcare sector, increasing penetration of the market players within the region, and increasing healthcare expenditure drives the regional markets of the Asia Pacific region. According to the 2017 data suggested by the Australian Institute of Health and Welfare, nearly USD 181 billion is spent on health in Australia.

On the other hand, the Middle East and Africa held least share in the Interventional Neurology Market due to the low per capita income, especially within the African region. The growth in this region is attributed to the rising cases neurological conditions. The burden of neurological disorders in African region has been increasing over the years. The annual incidence of stroke has been estimated to be 316 per 100 000 in Africa.

Key players

Some of the key players in the Interventional Neurology Market are 

• Abbott Laboratories
• Johnson & Johnson
• Boston Scientific Corporation
• Stryker Corporation
• Medtronic PLC
• Terumo Corporation
• Penumbra, Inc.
• Microport Scientific Corporation
• Merit Medical Systems, Inc.
• W.L. Gore & Associates, Inc.
• B. Braun Melsungen AG
• Cook Medical

Research Methodology

Market Research Future research is conducted by industry experts who offer insights into industry structure, market segmentation, assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analysing historical trends and current market positions. Furthermore, the varying trends of segments and categories geographically presented are studied and are estimated based on the primary and secondary research.

• Primary Research

Extensive primary research was conducted to gain a deeper insight of the market and the industry performance. In this particular report we have conducted primary surveys (interviews) with key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.

• Secondary Research

Secondary research was mainly used to collect and identify information useful for extensive, technical, market-oriented, and commercial study of the Interventional Neurology. It was also used to obtain key information about major players, market classification, and segmentation according to industry trends, geographical markets, and developments related to the market and perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company web sites, international organization of chemical manufacturers, some paid databases, and many others.Recent Development

March 2022

In March 2022, India Medtronic Private Limited, a wholly-owned subsidiary of Medtronic Plc. announced the launch of the Prospective Registry for Assessment of Acute Ischemic Stroke Patients Treated with the Neurothrombectomy Devices, which will be used to create a post-market registry to access the clinical outcomes associated with the use of Medtronic market-released revascularization devices in the patients experiencing acute ischemic stroke.

November 2020

In November 2020, the American Heart Association, in collaboration with the society of vascular and the interventional neurology and the John Wiley and Sons, launched a new open-access journal, Stroke: Vascular and interventional neurology, which will focus on the topics of the interventional, endovascular, medical and surgical management of the stroke and vascular disease of the brain, spinal cord and head and neck.

 Intended Audience

• Medical Device Companies
• Government and Private Laboratories
• Research and Development (R&D) companies
• Medical Research Laboratories
• Market Research and Consulting Service Providers

Interventional Neurology Market Segmentation 

Interventional Neurology Disease Pathology Outlook

• Cerebral Aneurysms
• Arteriovenous Malformation and Fistulas
• Ischemic Strokes
• Others

Interventional Neurology Product Outlook

• Aneurysm Coiling & Embolization Devices
• Embolic Coils
• Bare Detachable Coils
• Coated Detachable Coils
• Flow Diversion Devices
• Liquid Embolic Agents
• Cerebral Balloon Angioplasty and Stenting Systems
• Carotid Artery Stents
• Embolic Protection Systems
• Distal Filter Devices
• Balloon Occlusion Devices
• Neurothrombectomy Devices
• Clot Retrieval Devices
• Suction and Aspiration Devices
• Snares
• Support Devices
• Microcatheters
• Microguidewires

Interventional Neurology End User Outlook

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Research & Academic Institutes 
• Others